SLC1A3 and thyroid gland carcinoma: Finally, a role for CD133 cancer stem cell marker in modulation of thyroid cancer metabolism has been proposed, through CD133-dependent NF-kappaB-mediated induction of aspartate/glutamate transporter SLC1A3.